← Eichor
Condition: Drug Hypersensitivity Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Drug Hypersensitivity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks
NA · 1 location(s) · Pierre Fabre Dermo Cosmetique · NCT07014007Predictive Signature of Benralizumab Response
Phase 4 · 20 location(s) · Nantes University Hospital · NCT04565483Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Phase 4 · 21 location(s) · Hospices Civils de Lyon · NCT05841758Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction
NA · 2 location(s) · Jessa Hospital · NCT04979078Drug Survival of Target Therapies in Atopic Dermatitis
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06882148Effect of Genetic Polymorphisms on Response to Preoperative NSAIDs in Endodontic Postoperative Pain Management
NA · 1 location(s) · Ataturk University · NCT06937853Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
Phase 3 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06350825Diagnosing Drug Allergy: the T is the Key
NA · 1 location(s) · University Hospital, Antwerp · NCT06409884Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.
NA · 1 location(s) · NAOS Les Laboratoires · NCT06756438A Non-interventional, Prospective Study With Benralizumab
Phase N/A · 41 location(s) · AstraZeneca · NCT06422078Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sa
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT04199026Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer
NA · 1 location(s) · Oncosyne AS · NCT07171554Blood Sampling for Research Related to Sickle Cell Disease
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00542230Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge
Phase 3 · 1 location(s) · James Tarbox, MD · NCT06303128P4O2 ILD Extension
Phase N/A · 1 location(s) · Amsterdam UMC, location VUmc · NCT06644144Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer
NA · 1 location(s) · Peking Union Medical College Hospital · NCT05424692Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)
NA · 2 location(s) · Johns Hopkins University · NCT07164742Prospective Evaluation of Silk Fibroin Incision Dressings in ACL Reconstruction
NA · 1 location(s) · NYU Langone Health · NCT07217613A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Tre
Phase 2 · 1 location(s) · Qilu Hospital of Shandong University · NCT07264803Analysis of the Role of IgE Proteoforms in Health and Disease
Phase N/A · 1 location(s) · KU Leuven · NCT07328178Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Phase 1/Phase 2 · 66 location(s) · Genmab · NCT05579366Effect of Combined Probiotics and Vitamin D on Symptoms of Allergic Rhinitis
NA · 1 location(s) · Tanta University · NCT07115342Asthma Link Effectiveness Trial
NA · 1 location(s) · University of Massachusetts, Worcester · NCT06388460Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome
Phase N/A · 11 location(s) · University Hospital, Lille · NCT04330118Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Phase N/A · 1 location(s) · National Cancer Centre, Singapore · NCT04340024Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic
Phase 3 · 26 location(s) · Nick Beije · NCT07260435Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syn
Phase 2/Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05786768Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT02732860Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
Phase 3 · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05352178CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
Phase N/A · 1 location(s) · CorEvitas · NCT06238765
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.